These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35051895)

  • 1. Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive decline.
    Chen H; Wan H; Zhang M; Wardlaw JM; Feng T; Wang Y
    Parkinsonism Relat Disord; 2022 Feb; 95():70-76. PubMed ID: 35051895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.
    Park YW; Shin NY; Chung SJ; Kim J; Lim SM; Lee PH; Lee SK; Ahn KJ
    Mov Disord; 2019 Nov; 34(11):1672-1679. PubMed ID: 31322758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.
    Schrag A; Siddiqui UF; Anastasiou Z; Weintraub D; Schott JM
    Lancet Neurol; 2017 Jan; 16(1):66-75. PubMed ID: 27866858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased perivascular space volume in white matter and basal ganglia is associated with cognition in Parkinson's Disease.
    Donahue EK; Foreman RP; Duran JJ; Jakowec MW; O'Neill J; Petkus AJ; Holschneider DP; Choupan J; Van Horn JD; Venkadesh S; Bayram E; Litvan I; Schiehser DM; Petzinger GM
    Brain Imaging Behav; 2024 Feb; 18(1):57-65. PubMed ID: 37855955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High baseline perivascular space volume in basal ganglia is associated with attention and executive function decline in Parkinson's disease.
    Foreman RP; Donahue EK; Duran JJ; Schiehser DM; Petkus A; O'Neill J; Holschneider DP; Choupan J; Van Horn JD; Bayram E; Litvan I; Jakowec MW; Petzinger GM
    Brain Behav; 2024 Jul; 14(7):e3607. PubMed ID: 39010690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.
    Shi X; Zhou N; Sun B; Wu Y; Hu Y; Ning Y;
    J Alzheimers Dis; 2022; 90(3):1329-1337. PubMed ID: 36245373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease Patients.
    Ramirez J; Berberian SA; Breen DP; Gao F; Ozzoude M; Adamo S; Scott CJM; Berezuk C; Yhap V; Mestre TA; Marras C; Tartaglia MC; Grimes D; Jog M; Kwan D; Tan B; Binns MA; Arnott SR; Bartha R; Symons S; Masellis M; Black SE; Lang AE;
    Mov Disord; 2022 Jun; 37(6):1304-1309. PubMed ID: 35403259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ATN
    Cousins KAQ; Irwin DJ; Tropea TF; Rhodes E; Phillips J; Chen-Plotkin AS; Brumm MC; Coffey CS; Kang JH; Simuni T; Foroud TM; Toga AW; Tanner CM; Kieburtz KD; Mollenhauer B; Galasko D; Hutten S; Weintraub D; Siderowf AD; Marek K; Poston KL; Shaw LM;
    Neurology; 2024 Feb; 102(4):e208033. PubMed ID: 38306599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-visible enlarged perivascular spaces: imaging marker to predict cognitive impairment in older chronic insomnia patients.
    Wang XX; Cao QC; Teng JF; Wang RF; Yang ZT; Wang MG; Cao ZH
    Eur Radiol; 2022 Aug; 32(8):5446-5457. PubMed ID: 35286409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.
    Shams S; Martola J; Charidimou A; Larvie M; Granberg T; Shams M; Kristoffersen-Wiberg M; Wahlund LO
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glymphatic function from diffusion-tensor MRI to predict conversion from mild cognitive impairment to dementia in Parkinson's disease.
    Pang H; Wang J; Yu Z; Yu H; Li X; Bu S; Zhao M; Jiang Y; Liu Y; Fan G
    J Neurol; 2024 Aug; 271(8):5598-5609. PubMed ID: 38913186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson's disease.
    Fang Y; Gu LY; Tian J; Dai SB; Chen Y; Zheng R; Si XL; Jin CY; Song Z; Yan YP; Yin XZ; Pu JL; Zhang BR
    Aging (Albany NY); 2020 Nov; 12(24):25805-25818. PubMed ID: 33234732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoupling of Global Brain Activity and Cerebrospinal Fluid Flow in Parkinson's Disease Cognitive Decline.
    Han F; Brown GL; Zhu Y; Belkin-Rosen AE; Lewis MM; Du G; Gu Y; Eslinger PJ; Mailman RB; Huang X; Liu X
    Mov Disord; 2021 Sep; 36(9):2066-2076. PubMed ID: 33998068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
    Irwin DJ; Fedler J; Coffey CS; Caspell-Garcia C; Kang JH; Simuni T; Foroud T; Toga AW; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Weintraub D; Mollenhauer B; Galasko DR; Siderowf A; Marek K; Trojanowski JQ; Shaw LM;
    Ann Neurol; 2020 Sep; 88(3):574-587. PubMed ID: 32542885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of perivascular space visualization in basal ganglia and white matter hyperintensity lesion is a meaningful finding for subsequent cognitive decline.
    Sugai Y; Hiraka T; Shibata A; Taketa A; Tanae T; Moriya Y; Ohara S; Iseki C; Ohta Y; Kanoto M
    Acta Radiol; 2024 Jul; 65(7):792-799. PubMed ID: 38841771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cognitive decline with non-clinical markers in Parkinson's disease (PRECODE-2).
    Yousaf T; Pagano G; Niccolini F; Politis M
    J Neurol; 2019 May; 266(5):1203-1210. PubMed ID: 30820739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning-based prediction of longitudinal cognitive decline in early Parkinson's disease using multimodal features.
    Almgren H; Camacho M; Hanganu A; Kibreab M; Camicioli R; Ismail Z; Forkert ND; Monchi O
    Sci Rep; 2023 Aug; 13(1):13193. PubMed ID: 37580407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-Visible Perivascular Spaces Associated With Cognitive Impairment in Military Veterans With Traumatic Brain Injury Mediated by CSF P-Tau.
    Wang ML; Yang DX; Sun Z; Li WB; Zou QQ; Li PY; Wu X; Li YH
    Front Psychiatry; 2022; 13():921203. PubMed ID: 35873253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease.
    Parnetti L; Farotti L; Eusebi P; Chiasserini D; De Carlo C; Giannandrea D; Salvadori N; Lisetti V; Tambasco N; Rossi A; Majbour NK; El-Agnaf O; Calabresi P
    Front Aging Neurosci; 2014; 6():53. PubMed ID: 24744728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.
    Liu C; Cholerton B; Shi M; Ginghina C; Cain KC; Auinger P; ; Zhang J
    Parkinsonism Relat Disord; 2015 Mar; 21(3):271-6. PubMed ID: 25596881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.